Schedule of components of income tax expense (benefit) |
Schedule of components of income tax expense (benefit) |
|
|
|
|
|
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Expected federal income tax benefit at statutory rate |
|
$ |
9,464,954 |
|
|
$ |
7,184,840 |
|
Non-deductible expenses |
|
|
1,183,767 |
|
|
|
(288,249 |
) |
Research and development credit |
|
|
– |
|
|
|
595,244 |
|
Return to provision true up |
|
|
108,959 |
|
|
|
93,285 |
|
Change in valuation allowance |
|
|
(10,757,680 |
) |
|
|
(7,585,120 |
) |
Income tax benefit |
|
$ |
– |
|
|
$ |
– |
|
|
Schedule of deferred tax assets and liabilities |
Schedule of deferred
tax assets and liabilities |
|
|
|
|
|
|
|
|
2023 |
|
|
2022 |
|
Deferred tax assets |
|
|
|
|
|
|
|
|
Net operating losses |
|
$ |
15,468,757 |
|
|
$ |
9,106,430 |
|
Debt basis difference |
|
|
5,121,397 |
|
|
|
– |
|
Depreciation and amortization |
|
|
1,701,768 |
|
|
|
1,502,868 |
|
Research & development credit |
|
|
1,099,535 |
|
|
|
1,308,956 |
|
Lease liability |
|
|
246,704 |
|
|
|
322,167 |
|
Stock-based compensation |
|
|
3,235,732 |
|
|
|
3,103,037 |
|
Inventory |
|
|
152,749 |
|
|
|
1,290,968 |
|
Accrued expenses |
|
|
66,909 |
|
|
|
233,284 |
|
Capital loss carryover |
|
|
176,950 |
|
|
|
261,922 |
|
Dealer rebates |
|
|
459,713 |
|
|
|
161,469 |
|
Other |
|
|
21,828 |
|
|
|
15,605 |
|
Total |
|
|
27,752,042 |
|
|
|
17,306,705 |
|
Valuation allowance |
|
|
(27,171,016 |
) |
|
|
(16,661,612 |
) |
Net deferred tax asset |
|
|
581,026 |
|
|
|
645,093 |
|
Deferred tax liabilities |
|
|
|
|
|
|
|
|
Prepaid expenses |
|
|
(342,421 |
) |
|
|
(328,836 |
) |
Right-of-use assets |
|
|
(238,605 |
) |
|
|
(316,257 |
) |
Total net deferred taxes Deferred tax liabilities |
|
$ |
– |
|
|
$ |
– |
|
|